
Michael Burgess, MD @michaelcburgess
@US_FDA issued a revised fact sheet for health care providers including information on susceptibility of SARS-CoV-2 variants to each of the monoclonal antibody therapies available through an Emergency Use Authorization for the treatment of COVID-19. https://t.co/JzCOGsPnKo — PolitiTweet.org